In the current study, the observed increase in CD25 expression and the induction of Tregs suggest that the therapeutic effects of AdMSC-PD-L1-Akt cells may, in part, be mediated through the modulation of the immune response post-MI, creating a more conducive environment for myocardial repair and regeneration. The gene discussed is CD274; the disease is myocardial infarction.